{"name":"InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company","slug":"infacare-pharmaceuticals-corporation-a-mallinckrodt-company","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Stanate","genericName":"Stanate","slug":"stanate","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Stanate","genericName":"Stanate","slug":"stanate","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQTHpBWUtvejNfU2R3SHlwTWg3Rlc3cWROV0VvWlZUZ0FGazlsb0EyN2x1bFdlY0tTR2VRTk9FNHdzbWVPc2ZxVkZXaGN5dzA1bzBNOVBoUU82VGloOGZWWjlJU19sSE5IaHZvTThvUzZ4WHRHWEFoNVg1UUF0ZkVPWmhtTzJMa0RPc3VmeHpwZzU?oc=5","date":"2025-10-06","type":"pipeline","source":"citybiz","summary":"Traws Pharma Appoints John Leaman, MD, as Director - citybiz","headline":"Traws Pharma Appoints John Leaman, MD, as Director","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxOQ3UxTmtIZzVKR0phWTdHTDVGcEpkdFh5Qk5qUndrTTNReVhiOEp2Mzc5cjkwYXF1c3BJc2RodWNYekx0MFlkVE1QUGJua1Y0azNMRXUxS3RDM1VrZlY1QzJDb29pVFlTNGlaeTI4VndrOWFveDRvNHhIQ1ZpdGNsZ29tVWFUeElPSlFhTDhR?oc=5","date":"2024-12-17","type":"pipeline","source":"citybiz","summary":"Arthrosi Appoints John Leaman, M.D., to Its Board - citybiz","headline":"Arthrosi Appoints John Leaman, M.D., to Its Board","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gJBVV95cUxPdnA0U2JMSzBrQUt4cnpuUWRZeGljXzExWGlMZU5NSldob2x5R3FFNkdkUUVsaWFXSFo2T29YU3Y2Y09Oa0xOSHBOTU1COUVDUm1KNEpVVEJrcDBYcDNIWnlhbktjdERpc0xQRllYV1NCa1BEZkhIYXI4eDJaWVRBc1ZSdmpJYWtvYnMyNTBETEhZZHdEMGxwaVhBdERMOU9rMzVSYTBjajM0MmZBMTBIUXVmMjdjZ0hJeXhmTk9KajgxbkdhSWZ1Y2c3bEVLbHdWQWY2X1VFdDg5TVNUUS1ib095M3ExY21YMm93OUhUVzB3UW90T3pxOGU4WGtDcUVPOGdIbTg5OEQzVVdWOVotTzZOZ3BzMVFjbVZwYXJyRF9GcDJrZDJnTlBIbnd0ZEZZUmhQdHVHeHB2Nmtmcm9HNDFPQjBFbjdoTTNhb2dBWVNSNWIxVFhXNWZR?oc=5","date":"2017-09-25","type":"pipeline","source":"prnewswire.com","summary":"Mallinckrodt Completes Acquisition of InfaCare Pharmaceutical Corporation and Stannsoporfin, its Proprietary Therapy in Late-Stage Development for Newborns at Risk for Severe Jaundice - prnewswire.com","headline":"Mallinckrodt Completes Acquisition of InfaCare Pharmaceutical Corporation and Stannsoporfin, its Proprietary Therapy in ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPQmV1SklZRXZLXzVGM2xZZVpLMGRLSHdMVlBicWZBZVRYSGgySmJwV1dVMWNuOWdmb09rY084alVjbE9IWi1kNlBXcUdUeE4wenhyNHd2MUt0SWhCaXVGVUNxMUEwZHZobS1fbG0tYXZ1Y2VqbWdNemlhNWhxb3NMZktBdWdKV0xT?oc=5","date":"2017-08-07","type":"deal","source":"Contract Pharma","summary":"Mallinckrodt Buys InfaCare for $425M - Contract Pharma","headline":"Mallinckrodt Buys InfaCare for $425M","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2017-08-04","type":"deal","source":"prnewswire.com","summary":"Mallinckrodt To Acquire InfaCare Pharmaceutical Corporation And Stannsoporfin, Its Proprietary Therapy In Late-Stage Development For Treatment Of Newborns At Risk For Developing Severe Jaundice - prne","headline":"Mallinckrodt To Acquire InfaCare Pharmaceutical Corporation And Stannsoporfin, Its Proprietary Therapy In Late-Stage Dev","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}